Peregrine Asset Advisers, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1535227 Portland, OR

Position in VRTX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$289,593

+$29,707 QoQ

Shares Held

583

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#1,250

of 1,735 holders

Holding Since

Jun 2022

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Peregrine Asset Advisers, Inc. holds $789,611 across 5 Biotechnology names. VRTX ranks #1 (36.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	583	$289,593
2	RVMD	Revolution Medicines, Inc.	1,316	$246,460
3	KRYS	Krystal Biotech, Inc.	547	$203,303
4	CTMX	CytomX Therapeutics, Inc.	10,200	$38,250
5	TNYA	Tenaya Therapeutics, Inc.	16,245	$12,005

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$289,593	583	+0.2%	Shares	Sole	2026-08-10
2026-03-31	$259,886	582	-95.9%	Shares	Sole	2026-04-24
2023-06-30	$5,041,462	14,326	-4.0%	Shares	Sole	2023-08-07
2022-06-30	$4,203,179	14,916	—	Shares	Sole	2022-08-09
No filing history on record for this holder in this stock.